Gerald D. Cagle, Ph.D.

Chief Operating Officer, Cognoptix, Inc.
Former SVP, R&D and Chief Scientific Officer, Alcon Laboratories, Inc.
Dr. Cagle has served on our board of directors since July 2013. Dr. Cagle has served as Chief Operating Officer at Cognoptix, Inc., a biotechnology company focused on the diagnosis of Alzheimer’s disease, since December 2008. He is also Senior Advisor and Head of Business Development for GrayBug, LLC, a platform drug delivery company. Previously, Dr. Cagle served as Senior Vice President of Research and Development at Alcon Laboratories, Inc., from 1997 to 2008, assuming the responsibility of Chief Scientific Officer in 2006. He currently serves on the board of directors of Aerie Pharmaceuticals, Inc., a publicly held biopharmaceutical company. Dr. Cagle has also served on the Wilmer Eye Institute Advisory Council and is a member of the ARVO Foundation Board of Governors. Dr. Cagle received his B.S. degree from Wayland College and earned M.S and Ph.D. degrees from the University of North Texas.

Let’s get the conversation going

Questions? We’d love to hear from you.


Investor Menu